glp-1 kidney news GLP-1s are back in the — but this is a conversation we've explored on our channel before. From weight loss to heart, kidney, liver, sleep and metabolic health, the science is Real-World Evidence for GLP-1 Receptor

Terrible cravings

Compounds of trace elements: E1 (Fe) 40.0 mg, E6 (Zn) 11.2 mg, E5 (Mn) 8.4 mg, E4 (Cu) 2.0 mg, E2 (I) 0.25 mg, E8 (Se) 0.24 mg, E7 (Mo) 0.06 mg

This usually resolves by itself and there are no specific treatments

Furthermore, as oral semaglutide has recently entered phase III trials against Alzheimers disease, and injectable semaglutide is in the phase II trial of Parkinsons disease as well as in the phase III trial against diabetic eye diseases, the potential of specifically semaglutide in glaucoma is additionally endorsed

Jones 1,2,* Received: 04 December 2025 Revised: 29 December 2025 Accepted: 08 January 2026 Published: 12 January 2026 2026 The authors